Evelyn Mei Huang

Array ( [id] => 4410519 [patent_doc_number] => 06228866 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Condensed piperidine compound' [patent_app_type] => 1 [patent_app_number] => 9/524255 [patent_app_country] => US [patent_app_date] => 2000-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10737 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228866.pdf [firstpage_image] =>[orig_patent_app_number] => 524255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1450596 [patent_doc_number] => 06455538 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => '1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ols' [patent_app_type] => B1 [patent_app_number] => 09/523473 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10983 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455538.pdf [firstpage_image] =>[orig_patent_app_number] => 09523473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4331220 [patent_doc_number] => 06313141 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => '2-aminoalkylaminoquinolines as dopamine D4 ligands' [patent_app_type] => 1 [patent_app_number] => 9/445661 [patent_app_country] => US [patent_app_date] => 2000-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5713 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/313/06313141.pdf [firstpage_image] =>[orig_patent_app_number] => 445661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408490 [patent_doc_number] => 06271379 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Intermediates useful for the synthesis of huperzine A' [patent_app_type] => 1 [patent_app_number] => 9/520497 [patent_app_country] => US [patent_app_date] => 2000-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12231 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 262 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271379.pdf [firstpage_image] =>[orig_patent_app_number] => 520497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409823 [patent_doc_number] => 06300331 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Naphthalimidobenzamide derivatives' [patent_app_type] => 1 [patent_app_number] => 9/508044 [patent_app_country] => US [patent_app_date] => 2000-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28028 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300331.pdf [firstpage_image] =>[orig_patent_app_number] => 508044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272155 [patent_doc_number] => 06245777 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'N-(5-phenyl-tetrahydrofuranyl)methyl- and N-(6-phenyl-tetrahydropyranyl)methyl-substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols' [patent_app_type] => 1 [patent_app_number] => 9/510555 [patent_app_country] => US [patent_app_date] => 2000-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2455 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245777.pdf [firstpage_image] =>[orig_patent_app_number] => 510555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4304777 [patent_doc_number] => 06187787 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Bis(9-aminoacridine) DNA intercalating agents having antitumor activity' [patent_app_type] => 1 [patent_app_number] => 9/446171 [patent_app_country] => US [patent_app_date] => 2000-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2532 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187787.pdf [firstpage_image] =>[orig_patent_app_number] => 446171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1316265 [patent_doc_number] => 06608061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-19 [patent_title] => 'Bisaryl compound and medicament for cancer treatment comprising the same' [patent_app_type] => B2 [patent_app_number] => 09/424352 [patent_app_country] => US [patent_app_date] => 2000-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20722 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 1689 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/608/06608061.pdf [firstpage_image] =>[orig_patent_app_number] => 09424352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4269955 [patent_doc_number] => 06306911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Substituted amino acids as neutral sphingomyelinase inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/499426 [patent_app_country] => US [patent_app_date] => 2000-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11018 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306911.pdf [firstpage_image] =>[orig_patent_app_number] => 499426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4371592 [patent_doc_number] => 06288105 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Antithrombotic agents' [patent_app_type] => 1 [patent_app_number] => 9/423164 [patent_app_country] => US [patent_app_date] => 2000-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25603 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 402 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288105.pdf [firstpage_image] =>[orig_patent_app_number] => 423164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4401032 [patent_doc_number] => 06264733 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Pigment particle growth and/or crystal phase directors' [patent_app_type] => 1 [patent_app_number] => 9/496494 [patent_app_country] => US [patent_app_date] => 2000-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5846 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/264/06264733.pdf [firstpage_image] =>[orig_patent_app_number] => 496494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1436158 [patent_doc_number] => 06355802 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Process to prepare (5R)-(methylamino)-5,6-dihydro-4H-imidazo4,5,1-ij-quinolin-2(1h)-one' [patent_app_type] => B1 [patent_app_number] => 09/494750 [patent_app_country] => US [patent_app_date] => 2000-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4544 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355802.pdf [firstpage_image] =>[orig_patent_app_number] => 09494750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476498 [patent_doc_number] => 20020151714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'PROCESS FOR PREPARING 1,4-DISUBSTITUTED PIPERIDINE COMPOUNDS' [patent_app_type] => new [patent_app_number] => 09/380835 [patent_app_country] => US [patent_app_date] => 2000-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3176 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151714.pdf [firstpage_image] =>[orig_patent_app_number] => 09380835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470330 [patent_doc_number] => 06407120 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Neuropeptide Y antagonists' [patent_app_type] => B1 [patent_app_number] => 09/494197 [patent_app_country] => US [patent_app_date] => 2000-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9633 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 383 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407120.pdf [firstpage_image] =>[orig_patent_app_number] => 09494197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4346318 [patent_doc_number] => 06284756 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Antithrombotic agents' [patent_app_type] => 1 [patent_app_number] => 9/423166 [patent_app_country] => US [patent_app_date] => 2000-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31157 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 424 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284756.pdf [firstpage_image] =>[orig_patent_app_number] => 423166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586206 [patent_doc_number] => 06358968 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'N-substituted urea inhibitors of farnesyl-protein transferase' [patent_app_type] => B1 [patent_app_number] => 09/484375 [patent_app_country] => US [patent_app_date] => 2000-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14088 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358968.pdf [firstpage_image] =>[orig_patent_app_number] => 09484375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1567754 [patent_doc_number] => 06376676 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Intermediates in the synthesis of ()-camptothecin and related compounds and synthesis thereof' [patent_app_type] => B1 [patent_app_number] => 09/480824 [patent_app_country] => US [patent_app_date] => 2000-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 7865 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376676.pdf [firstpage_image] =>[orig_patent_app_number] => 09480824 [rel_patent_id] =>[rel_patent_doc_number] =>)